Skip to content

Efficacy study on the effects of complex acid treatment, salicylic acid shampoo, and scalp moisturizing serum on the scalp microenvironment.

Efficacy study on the effects of complex acid treatment, salicylic acid shampoo, and scalp moisturizing serum on the scalp microenvironment.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129627
Enrollment
Unknown
Registered
2026-08-07
Start date
2025-04-24
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic dermatitis

Interventions

Complex acid group:Ximeien Scalp Oil?Control Balancing Compound Acid
Scalp Moisturizing Serum Group:Ximeien Scalp Moisturizing and Repairing Serum
Ketoconazole Shampoo Group:Ketoconazole Shampoo (Caile)
Salicylic Acid Shampoo Group:Ximeien Salicylic Acid Oil?Control Anti?Dandruff Shampoo

Sponsors

The 2nd Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed as mild-moderate SSD; 2. Outpatients between 18 and 75 years of age; 3. No topical or systemic therapy for seborrheic dermatitis has been administered within 4 weeks before baseline; 4. Able to complete study-related self-assessments and written records; 5. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to complex acid, salicylic acid shampoo, scalp moisturizing serum, or ketoconazole; 2. Use of preparations containing salicylic acid, ketoconazole, or other ingredients of the study products within 4 weeks prior to enrollment; 3. Women who were planning pregnancy, pregnant, or lactating; 4. Patients with severe cardiac, cerebral, hepatic, or renal diseases, psychiatric disorders, or overt immunosuppression; 5. Participation in other interventional clinical trials within the past 3 months; 6. Any other conditions judged by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
The state of your gut microbes;

Countries

China

Contacts

Public ContactZhao Hengguang

The 2nd Affiliated Hospital of Chongqing Medical University

zhgvip@163.com+86 23 6369 3935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026